| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 364.00M | 368.10M | 392.10M | 441.00M | 396.30M | 324.20M |
| Gross Profit | 0.00 | 160.10M | 165.00M | 169.30M | 140.80M | 118.40M |
| EBITDA | 48.00M | 18.70M | 55.30M | 54.50M | 48.80M | 35.00M |
| Net Income | 12.60M | 3.50M | 26.80M | 16.80M | 25.70M | 15.00M |
Balance Sheet | ||||||
| Total Assets | 377.50M | 388.00M | 425.30M | 446.20M | 359.50M | 312.20M |
| Cash, Cash Equivalents and Short-Term Investments | 27.00M | 22.70M | 30.80M | 29.00M | 27.40M | 28.30M |
| Total Debt | 89.50M | 80.10M | 90.30M | 103.60M | 42.80M | 42.00M |
| Total Liabilities | 175.00M | 180.10M | 202.90M | 235.80M | 159.20M | 163.80M |
| Stockholders Equity | 202.50M | 207.90M | 222.40M | 210.40M | 200.30M | 148.40M |
Cash Flow | ||||||
| Free Cash Flow | 21.70M | 11.60M | 29.30M | 18.50M | 9.20M | 50.50M |
| Operating Cash Flow | 26.90M | 18.50M | 36.60M | 24.50M | 14.60M | 53.30M |
| Investing Cash Flow | 2.80M | -3.40M | -7.30M | -84.30M | -5.40M | -2.80M |
| Financing Cash Flow | -24.10M | -23.40M | -26.00M | 64.30M | -11.70M | -70.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £270.34M | 117.95 | 6.14% | 3.48% | -3.93% | 41.83% | |
70 Neutral | £530.40M | ― | 22.50% | 5.91% | -4.70% | -2.21% | |
66 Neutral | £91.22M | 7.45 | 18.04% | 4.63% | 12.60% | 6.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £114.32M | 13.69 | 9.23% | 3.97% | 5.51% | -33.75% | |
60 Neutral | £756.18M | 18.00 | 6.89% | 3.19% | 5.88% | 107.36% | |
57 Neutral | £162.37M | 212.00 | 1.61% | 4.39% | -3.51% | -67.38% |